Valuation: Prenetics Global Limited

Market Cap 385M 338M 317M 290M 542M 36.85B 546M 3.81B 1.48B 18.79B 1.44B 1.41B 60.91B P/E 2026 *
-6.56x
P/E 2027 * -16.1x
Enterprise Value 385M 338M 317M 290M 542M 36.85B 546M 3.81B 1.48B 18.79B 1.44B 1.41B 60.91B EV / Sales 2026 *
1.72x
EV / Sales 2027 * 0.95x
Free-Float
85.46%
Yield 2026 *
-
Yield 2027 * -
1 day-0.83%
1 week+3.13%
Current month-13.49%
1 month+12.43%
3 months+14.01%
6 months+5.82%
Current year+44.19%
1 week 22.35
Extreme 22.35
25.01
1 month 21.55
Extreme 21.55
27.24
Current year 14
Extreme 14
27.24
1 year 11.36
Extreme 11.365
27.24
3 years 2.85
Extreme 2.85
27.24
5 years 2.85
Extreme 2.85
131.25
10 years 2.85
Extreme 2.85
131.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 52 31/12/2013
Chief Executive Officer 47 31/12/2013
Director of Finance/CFO 41 31/12/2017
Director TitleAgeSince
Chairman 47 31/12/2013
Director/Board Member 38 -
Director/Board Member - 15/02/2026
Date Insider Type Main position Quantity % Market Cap. Importance
04/09/26 Exercice

Director

4,000 0.0257%
25/08/26 Buy

CFO of IM8 (US) LLC

5,100 0.0328%
24/08/26 Buy

Chief Executive Officer

17,181 0.1104%
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%+3.13%+83.29%+217.47% 385M
-0.19%+1.10%-23.84%+5.44% 179B
-1.62%-3.56%-5.96%+11.25% 114B
-0.68%-1.95%+3.27%+67.94% 59.59B
-0.26%+0.37%-2.14%-31.18% 49.72B
+2.12%+1.90%+10.19%+49.71% 47.75B
-2.01%+0.45%+28.64%+0.26% 33.11B
-0.38%+3.97% - - 30.09B
+1.29%+3.83%+49.87%+0.90% 26.45B
-0.39%+6.03%+9.83%-10.53% 22.79B
Average -0.44%+1.30%+17.02%+34.58% 56.32B
Weighted average by Cap. -0.85%+0.09%-3.48%+13.15%

Financials

2026 *2027 *
Net sales 224M 197M 185M 169M 316M 21.45B 318M 2.22B 860M 10.94B 841M 823M 35.46B 404M 354M 333M 304M 569M 38.67B 573M 4B 1.55B 19.71B 1.52B 1.48B 63.91B
Net income -61.71M -54.17M -50.92M -46.55M -86.99M -5.91B -87.63M -612M -237M -3.01B -232M -227M -9.77B -24.22M -21.25M -19.98M -18.27M -34.13M -2.32B -34.39M -240M -93.03M -1.18B -90.94M -88.95M -3.83B
Net Debt - -
Logo Prenetics Global Limited
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Employees
98
Date Price Change Volume
23/09/26 US$22.71 -0.83% 245,767
22/09/26 US$22.90 -5.92% 240,917
21/09/26 US$24.34 +0.62% 112,652
18/09/26 US$24.19 0.00% 123,914
17/09/26 US$24.19 +9.85% 279,578
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
22.71USD
Average target price
35.86USD
Spread / Average Target
+57.89%

Quarterly revenue - Rate of surprise